These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5286580)

  • 1. Synthesis of 1-beta-L-arabinofuranosylcytosine, the enantiomer of cytosine arabinoside.
    Tolman RL; Robins RK
    J Med Chem; 1971 Nov; 14(11):1112. PubMed ID: 5286580
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acids. 12. Synthesis of the L enantiomer of 1- -arabinofuranosylcytosine and of O 2 ,O 2' -anhydro-1- -D-arabinofuranosylcytosine.
    Gish DT; Neil GL; Wechter WJ
    J Med Chem; 1971 Sep; 14(9):882-3. PubMed ID: 5140018
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract]   [Full Text] [Related]  

  • 5. Peroral therapy with cytosine arabinoside. Preliminary laboratory and clinical findings.
    Goldenberg DM; Schricker KT; von der Emde J; Sögtrop HH
    Arzneimittelforschung; 1968 Jun; 18(6):712-4. PubMed ID: 5755808
    [No Abstract]   [Full Text] [Related]  

  • 6. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
    Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleosides. XLVII. Synthesis of some N4-substituted derivarives of 1-beta-D-arabinofuranosylcytosine and -5-fluorocytosine.
    Wempen I; Miller N; Falco EA; Fox JJ
    J Med Chem; 1968 Jan; 11(1):144-8. PubMed ID: 5637159
    [No Abstract]   [Full Text] [Related]  

  • 8. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
    Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
    J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2'-O-methyl ether of 1-beta-D-arabinofuranosylcytosine.
    Montgomery JA; Laseter AG
    J Med Chem; 1974 Mar; 17(3):360-1. PubMed ID: 4811237
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-prednisolone and -cortisol.
    Hong CI; Nechaev A; West CR
    Biochem Biophys Res Commun; 1980 Jun; 94(4):1169-76. PubMed ID: 6249301
    [No Abstract]   [Full Text] [Related]  

  • 11. 2'-O-nitro-1-beta-D-arabinofuranosylcytosine. A new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity.
    Chwang TL; Fridland A; Avery TL
    J Med Chem; 1983 Feb; 26(2):280-3. PubMed ID: 6827546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acids. 11. Synthesis of 5'-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity.
    Gish DT; Kelly RC; Camiener GW; Wechter WJ
    J Med Chem; 1971 Dec; 14(12):1159-62. PubMed ID: 5116227
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
    Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
    Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of the cancer chemotherapeutic effect of cytosine arabinoside entrapped in liposomes on mouse leukemia L-1210.
    Kobayashi T; Tsukagoshi S; Sakurai Y
    Gan; 1975 Dec; 66(6):719-20. PubMed ID: 1225724
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine.
    Schwendener RA; Schott H
    Int J Cancer; 1992 May; 51(3):466-9. PubMed ID: 1592536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.
    Neil GL; Wiley PF; Manak RC; Moxley TE
    Cancer Res; 1970 Apr; 30(4):1047-54. PubMed ID: 5504347
    [No Abstract]   [Full Text] [Related]  

  • 17. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).
    Shackney SE
    Cancer Chemother Rep; 1970 Dec; 54(6):399-429. PubMed ID: 5527022
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
    Neil GL; Moxley TE; Manak RC
    Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
    Kline I; Venditti JM; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL; Roberts D
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.